Young Bio

Young Bio is transforming health care by restoring your young biology. They combine the current best science with proprietary AI, diagnostics, and therapies, with options for every budget level. Revenue streams will include SAAS, franchising, outlicensing, and sales of diagnostics and therapies. Their team includes Stanford University scientists, a physician who founded and runs a successful chain of clinics (not competing), and a wellness marketer. They have a prototype clinic in Mountain View, California. They are a spin-off of Rejuvenation Technologies, and their lead investor is the same for both companies. WeYoung Bio is raising up to $5M on SAFEs with $20M post-money cap with minimum check size of $25k. Their lead investor has committed $500k.